Skip to main content
SpringerLink
Log in

The Pathology of the Uremic Bone Lesion

  • Chapter
Book cover Chronic Renal Disease

  • 118 Accesses

Abstract

Renal osteodystrophy is a generic term that encompasses the array of biochemical and morphological derangements of bone that attend renal insufficiency. The insights gained into the genesis and, particularly, the natural history of this family of disorders are a reflection of the greater longevity of the uremic patient and, hence, the opportunity for skeletal dysfunctions to become clinically manifest.

Supported in part by NIH Grant AM-11674.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Malluche HH, Ritz E, Lange HP, Kutschera J, Hodgson M, Seiffert, U, Schoeppe W: Bone histology in incipient and advanced renal failure. Kidney Int 9:355, 1976.

    Article  PubMed  CAS  Google Scholar 

  2. Cohen MEL, Cohen GF, Ahad V, Kaye M: Renal osteodystrophy in patients on chronic haemodialysis. A radiological study. Clin Radiol 21:124, 1970.

    Article  PubMed  CAS  Google Scholar 

  3. Frost HM: Tetracycline-based histological analysis of bone remodeling. Cale Tiss Res 3:211, 1969.

    Article  CAS  Google Scholar 

  4. Milch RA, Rail DP, Tobie JE: Fluorescence of tetracycline antibiotics in bone. J Bone Joint Surg (AM) 40:897, 1958.

    Google Scholar 

  5. Urist MR, Ibsen KH: Chemical reactivity of mineralized tissue with Oxytetracycline. Arch Pathol 76:28, 1963.

    Google Scholar 

  6. Harris WH, Jackson RJ, Jowsey J: The in vivo distribution of tetracycline in canine bone. J Bone Joint Surg (AM) 44:1308, 1962.

    Google Scholar 

  7. Tam CS, Reed R, Cruickshand B: Bone growth kinetics: I. Modifications of the tetracycline labeling technique. J Pathol 113:27, 1973.

    Article  Google Scholar 

  8. Meunier P, Edouard C, Richard D, Laurent D: Histomorphometry of osteoid tissue. The hyperosteoidoses, in Meunier PJ (ed): Bone Histomorphometry. Toulouse, France, Sociétaé de la Nouvelle Imprimerie Fournié, 1977.

    Google Scholar 

  9. Termine JD: Mineral chemistry and skeletal biology. Clin Orthop 85:207, 1972.

    Article  PubMed  CAS  Google Scholar 

  10. Burnell JM, Teubner E, Wergedal JE, Sherrard DJ: Bone crystal maturation in renal osteodystrophy in humans, J Clin Invest 53:52, 1974.

    Article  PubMed  CAS  Google Scholar 

  11. Russell JE, Termine JD, Avioli LV: Abnormal bone mineral maturation in the chronic uremic state. J Clin Invest 52:2848, 1973.

    Article  PubMed  CAS  Google Scholar 

  12. Teitelbaum SL, Hruska KA, Shieber W, Debnam JW, Nichols SH: Tetracycline fluorescence in uremic and primary hyperparathyroid bone. Kidney Int 12:366, 1977.

    Article  PubMed  CAS  Google Scholar 

  13. Russell JE, Avioli LV, Mechanic G: The nature of the collagen cross-links in bone in the chronic uraemic state. Biochem J 145:119, 1975.

    PubMed  CAS  Google Scholar 

  14. Teitelbaum SL, Bergfeld MA, Freitag J, Hruska KA: Accelerated bone formation in end stage renal disease, in Norman AW, Schaefer K, von Herrath D, Grigoleit H-G, Coburn JW, DeLuca HF, Mawer EB, Suda T (eds): Vitamin D: Basic Research and Its Clinical Application. Berlin, Water de Gruyter, 1979, p. 373.

    Google Scholar 

  15. Canterbury JM, Reiss E: Multiple immunoreactive molecular forms of parathyroid hormone in human serum. Proc Soc Exp Biol Med 140:1393, 1972.

    PubMed  CAS  Google Scholar 

  16. Canterbury JM, Levey GS, Reiss E: Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments. J Clin Invest 52:524, 1973.

    Article  PubMed  CAS  Google Scholar 

  17. Eastwood JB, Stamp TCB, Harris E, De Wardener HE: Vitamin-D deficiency in the osteomalacia of chronic renal failure. Lancet 2:7997, 1976.

    Google Scholar 

  18. Goldstein DA, Oda Y, Kurokawa K, Massry SG: Blood levels of 25-hydroxyvitamin D in nephrotic syndrome. Studies in 26 patients. Ann Intern Med 87:664, 1977.

    PubMed  CAS  Google Scholar 

  19. Shen F, Baylink DJ, Sherrard DJ, Shen L, Maloney NA, Wergedal JE: Serum immuno-reactive parathyroid hormone and 25-hydroxyvitamin D in patients with uremic bone disease. J Clin Endocrinol Metab 40:1009, 1975.

    Article  PubMed  CAS  Google Scholar 

  20. Teitelbaum SL, Bone JM, Stein PM, Gilden JJ, Bates M, Boisseau VC, Avioli LV: Calcifediol in chronic renal insufficiency. Skeletal response. JAMA 235:164, 1976.

    Article  PubMed  CAS  Google Scholar 

  21. Pierides AM, Skillen AW, Ellis HA: Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: A study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1αOHD3 and 1,25(OH)2D3. J Lab Clin Med 93:899, 1979.

    PubMed  CAS  Google Scholar 

  22. Frost HM, Griffith DL, Jee WSS, Rimmel D, McCandlis RP Teitelbaum SL: Histomor-phometric changes in trabecular bone of renal failure patients treated with calcifediol. Metabol Bone Dis Rel Res 2:285, 1981.

    Article  Google Scholar 

  23. Russell JE, Roberts ML, Teitelbaum SL, Stein PM, Avioli LV: The therapeutic effects of 25-hydroxyvitamin D3 on renal osteodystrophy. Biochemical and morphometric analyses. Min Electrolyte Metab 1:129, 1978.

    CAS  Google Scholar 

  24. Eastwood JB, Bordier PJ, Clarkson EM, Tun Chot S, De Wardener HE: The contrasting effects on bone histology of vitamin D and of calcium carbonate in the osteomalacia of chronic renal failure. Clin Sci Mol Med 47:23, 1974.

    PubMed  CAS  Google Scholar 

  25. Hruska KA, Teitelbaum SL, Kopelman R, Richardson CA, Miller P, Debnam J, Martin K, Slatopolsky E: The predictability of the histological features of uremic bone disease by non-invasive techniques. Metabol Bone Dis Rel Res 1:39, 1978.

    Article  Google Scholar 

  26. Mosekilde L, Meisen F: A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism. Acta Med Scand 204:97, 1978.

    Article  PubMed  CAS  Google Scholar 

  27. Goldsmith RS: Discussion. Fed Proc 29:1198, 1970.

    PubMed  CAS  Google Scholar 

  28. Goldsmith RS, Woodhouse CF, Ingbar SH, Segal D: Effect of phosphate supplements in patients with fractures. Lancet 1:7492, 1967.

    Google Scholar 

  29. Duursma SA, Visser WJ, Dorhout Mees EJ, Njio L: Serum calcium, phosphate and alkaline phosphatase and morphometric bone examinations in 30 patients with renal insufficiency. Calc Tiss Res 16:129, 1974.

    Article  CAS  Google Scholar 

  30. Sherrard DJ, Baylink DJ, Wergedal JE, Maloney NA: Quantitative histological studies on the pathogenesis of uremic bone disease. J Clin Endocrinol Metab 39:119, 1974.

    Article  PubMed  CAS  Google Scholar 

  31. Debnam JW, Bates ML, Kopelman RC, Teitelbaum SL: Radiological/pathological correlations in uremic bone disease. Radiology 125:653, 1977.

    PubMed  CAS  Google Scholar 

  32. Teitelbaum SL, Russell JE, Bone JM, Gilden JJ, Avioli LV: The relationship of biochemical and histometric determinants of uremic bone. Arch Pathol Lab Med 103:228, 1979.

    PubMed  CAS  Google Scholar 

  33. Boskey AL, Posner AS: Magnesium stabilization of amorphous calcium phosphate: A kinetic study. Mat Res Bull 9:907, 1974.

    Article  CAS  Google Scholar 

  34. Ellis HA, McCarthy JH, Herrington J: Bone aluminum in haemodialyzed patients and in rats injected with aluminum chloride: Relationship to impaired bone mineralisation. J Clin Pathol 32:832, 1979.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Bone and Mineral Metabolism, and Department of Pathology and Laboratory Medicine, The Jewish Hospital of St. Louis, Washington University School of Medicine, St. Louis, Missouri, 63110, USA

    Steven L. Teitelbaum

Authors
  1. Steven L. Teitelbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Washington University School of Medicine, St. Louis, Missouri, USA

    Saulo Klahr M.D.

  2. National Institutes of Health, Bethesda, Maryland, USA

    Nancy Boucot Cummings M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Plenum Publishing Corporation

About this chapter

Cite this chapter

Teitelbaum, S.L. (1985). The Pathology of the Uremic Bone Lesion. In: Cummings, N.B., Klahr, S. (eds) Chronic Renal Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4826-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4826-9_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4828-3

  • Online ISBN: 978-1-4684-4826-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation